Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank

PLoS ONE - United States
doi 10.1371/journal.pone.0159924
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Letter: HBV/HCV Coinfection in the Era of Direct-Acting Antivirals

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Survival of HIV/HCV Co-Infected Patients Before Introduction of HCV Direct Acting Antivirals (DAA)

Scientific Reports
Multidisciplinary
2019English

Editorial: Good News to Patients With Thalassaemia-HCV Clearance Made Easy With Direct Acting Antivirals. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Imaging Findings of Hepatocellular Carcinoma That Developed After HCV Eradication With Direct-Acting Antivirals

Acta Hepatologica Japonica
Hepatology
2019English

Editorial: Direct Acting Antivirals - Not the Be-All and End-All in HIV/HCV Co-Infection. Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

A Study of the Impact of Treatment Response to Direct Acting Antivirals on Serum Lipid Profile in Egyptian Patients With Chronic HCV Infection

The Medical Journal of Cairo University
2019English

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents

Frontiers in Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy